Sunnyvale, CA, United States of America

David Mark Rotstein



 

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1999-2014

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Mark Rotstein

Introduction

David Mark Rotstein is a prominent inventor based in Sunnyvale, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of 15 patents to his name, Rotstein's work has had a substantial impact on medical research and treatment options.

Latest Patents

Among his latest patents are "Inhibitors of JNK - Compounds of formula I" and "Heterocyclic antiviral compounds." The latter patent focuses on chemokine receptor antagonists, specifically 3,7-diazabicyclo[3.3.0]octane compounds. These compounds serve as antagonists of chemokine CCR5 receptors, which are crucial for treating or preventing human immunodeficiency virus (HIV) infections, as well as for treating AIDS or AIDS-related complex (ARC). The invention also outlines methods for treating diseases that can be alleviated with CCR5 antagonists, including pharmaceutical compositions and processes for preparing the compounds.

Career Highlights

David Mark Rotstein has worked with notable companies in the pharmaceutical industry, including Syntex (U.S.A.) Inc. and Roche Palo Alto LLC. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Rotstein has collaborated with several professionals in the field, including Eric Brian Sjogren and David Michael Goldstein. These collaborations have likely enhanced his research and development efforts.

Conclusion

David Mark Rotstein's innovative work in pharmaceuticals has led to significant advancements in the treatment of various diseases. His contributions continue to influence the medical field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…